Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase.
Mutations in the quinolone resistance-determining regions (QRDR) of GyrA and GyrB.
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
Mutations in gyrA and gyrB were associated with quinolone resistance or hypersusceptibility.
Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones; CARD accession: CARD:3003295
Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays.
Mutations in gyrA lead to false-positive fluoroquinolone resistance results
Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
Mutations in gyrA are associated with fluoroquinolone resistance.
First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
The double substitution T80A-A90G in GyrA was found to confer hypersusceptibility to fluoroquinolones.
Tuberculosis drug resistance mutation database.
Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays.
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research